Substituted xanthine derivatives

US10329292B2 · kind B2 · utility

Assignees

• Boehringer Ingelheim International GmbH · DE
• Hydra Biosciences, LLC · US

Inventors

• Kai Gerlach · Biberach, DE
• Christian Eickmeier · Mittelbiberach, DE
• Achim Sauer · Ravensburg, DE
• Stefan Just · Biberach an der Riß, DE
• Bertrand L. Chenard · Waterford, US

Key dates

• Filing date: Jul 10, 2018
• Grant date: Jun 25, 2019
• Expiry date: Jul 10, 2038

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K2121/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to substituted xanthine derivatives, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment of conditions having an association with TRPC5 containing ion channels.